Created to simultaneously screen for several of the most common autoantibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE), the Maverick ENA 4 and ENA 6 assay kits are the first available for the Maverick Detection System. Their simplified one-step workflow delivers accurate results in 15 minutes and can be run using very small volume samples from a variety of matrices, including serum and plasma. The ENA 4 assay tests for the presence of four of the most commonly measured extractable nuclear antigens (ENA), including SS-A, SS-B, Sm and RNP, while the ENA 6 assay includes two additional commonly measured antigens–Scl-70 and Jo-1, so covering six multiplexed tests per sample. The assay results are highly reproducible, show excellent correlation to ELISA and are up to ten times more sensitive. The assays are available to participants in the company’s Early Access programme, which enables scientists to gain pre-launch access to multiplexed autoantibody assays and the Maverick Detection System. This uses a proprietary chip based on silicon photonics to simultaneously analyse multiple proteins from a single small sample. The multiplexing technology simultaneously screens for the detection of autoantibodies using a one-step process that eliminates the washes, incubations, reagents and processing steps typically associated with other technologies. Semi-quantitative results are reported for each analyte, eliminating the need for reflex testing. The assays are simple to use and rapid – results are available in only 15 minutes, including just two minutes of hands-on time. A number of higher plexed assays for autoimmune diseases, including rheumatoid arthritis, celiac disease and others, are also in development.
Read more

The new DocUReader 2 system is designed for physician’s offices and smaller laboratories to read and evaluate the LabStrip U11 Plus urine test strips with 50 samples / hour throughput.   The compact design of this lightweight instrument offers the broadest features and highest flexibility available on any desktop size urine analyzer. Auto start functionality and advanced, patented detection technique guarantee fast and accurate results. User friendly software ensures flexible testing and reporting options as well as effective data management. Manual entry of color and turbidity data improves clinical utility. Automated result and worklist transmission is enabled by LIS connectivity. More accurate data entry and reduced transcription errors can be achieved by optional barcode reader and external keyboard. Continuing the mission of the previous DocUReader, the new instrument features simple operation, cost efficiency, and high quality. The DocUReader 2 Pro additionally provides enhanced quality control and connectivity capabilities, operator management, and extended memory capacity.

More info – contact: sales@e77.hu
Read more

The RX daytona plus provides high quality testing on a compact, easy to use clinical chemistry analyser with accurate results. A fully automated, random access, benchtop analyser, it features a throughput of 450 tests per hour including ISE. Its comprehensive and flexible test menu allows the consolidation of a wide range of routine and specialized tests including routine chemistries, specific proteins, therapeutic drugs and drugs of abuse. Dedicated RX support teams provide technical support as needed, maximizing laboratory efficiency.
Read more

This compact 30 test/hour analyser is designed for daily use in labs with low throughput and offers all the qualities of a 60 test/hour instrument at an aff ordable cost. The COUNTENDER 30 features 20 parameters, 3 histograms and excellent CVs. It outclasses most 60 tests/hour analysers in terms of performance and quality of results and is top of its category, providing results in under 2mins. It also features very low reagent consumption. Combining simplified maintenance and long shelf-life of the company’s reagents (up to 36 months), the blood cell counter has low servicing requirements and enables signifi cant cost per test reduction for labs.
Read more

The β-Hydroxybutyrate LiquiColor reagent system assays levels of the ketone β-hydroxybutyrate (BHB) in serum and plasma for the clinical diagnosis and monitoring of diabetes mellitus, alcoholism, glycogen storage disease, high fat/low carbohydrate diets, pregnancy, alkalosis, ingestion of isopropyl alcohol and salicylate poisoning. As BHB is the main ketone produced during ketosis (~78%), the blood assay provides a better tool than the nitroprusside test strips commonly used for the detection of ketone bodies in urine, which only detect 22% of ketones present. BHB also demonstrates excellent stability, making it the most reliable indicator of clinically relevant ketosis and ketoacidosis. This reagent produces quantitative and objective results and provides an excellent tool for diff erentiating metabolic acidosis and monitoring therapy. Its precise and sensitive quantitative results enable earlier detection of ketosis and faster patient treatment, thus improving Emergency Room and Critical Decision Unit throughput and efficiency.
Read more